Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...
Despite rebukes by two federal circuit courts, an HHS sub-agency continues to overstep its authority when administering a ...
As a next step, they plan to conduct tests in larger animals. The authors acknowledge funding from the U.S. National ...
Hosted on MSN11h
Novavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call TranscriptNovavax, Inc. (NASDAQ:NVAX) Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good morning and welcome to Novavax' ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...
Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab, AstraZeneca’s benralizumab, Amgen Inc ...
Lixisenatide is a daily injection. It is no longer available in the U.S. [14] Adlyxin: Name-brand version of Lixisenatide ...
There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have joined forces to build an AI-powered tool designed to ...
" I’m honored to join Innate Pharma at such a pivotal moment in its evolution,”said Jonathan Dickinson, Chief Executive Officer of Innate Pharma. “ We achieved notable regul ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback